▁Eth 9.234375
ical 1.8935546875
▁Hold 11.5859375
ings 0.38330078125
▁Target 7.59375
s 0.471923828125
▁the 3.498046875
▁US 5.15234375
▁Market 2.61328125
▁with 1.396484375
▁Sh 6.4765625
arp 3.478515625
▁R 4.9765625
ise 0.42041015625
▁in 0.08258056640625
▁R 6.125
& 1.9794921875
D 0.0208282470703125
▁Sp 1.86328125
ending 0.406005859375
▁▁ 14.484375
<0x0A> 0.259521484375
<0x0A> 4.95703125
E 2.361328125
th 0.08111572265625
ical 0.0035552978515625
▁Hold 0.0179901123046875
ings 0.00152587890625
, 2.205078125
▁the 1.40625
▁UK 3.115234375
- 1.1015625
based 0.10211181640625
▁bi 4.484375
ote 0.39404296875
ch 0.9560546875
▁company 0.740234375
▁focused 2.73046875
▁on 0.01386260986328125
▁developing 1.62109375
▁gene 4.05078125
▁ther 0.63916015625
ap 0.5048828125
ies 0.00016248226165771484
▁for 0.61865234375
▁rare 1.890625
▁dise 0.68408203125
ases 6.830692291259766e-05
, 0.1790771484375
▁announced 2.53125
▁a 2.388671875
▁ 1.6591796875
7 2.583984375
5 1.421875
% 0.212890625
▁increase 0.35791015625
▁in 0.031890869140625
▁research 1.6728515625
▁and 0.06292724609375
▁development 0.00638580322265625
▁sp 0.908203125
ending 0.0004968643188476562
▁for 1.5439453125
▁the 1.283203125
▁coming 4.046875
▁fis 2.6484375
cal 0.0003173351287841797
▁year 0.01465606689453125
▁as 2.6875
▁it 0.47998046875
▁looks 2.26953125
▁to 0.034271240234375
▁acceler 3.802734375
ate 0.001251220703125
▁appro 7.359375
val 0.0002510547637939453
▁of 0.93994140625
▁its 0.2159423828125
▁lead 1.0537109375
▁candidate 1.5546875
▁treatment 5.5546875
▁and 4.16796875
▁expand 1.1962890625
▁into 1.390625
▁the 0.20751953125
▁luc 2.349609375
r 7.832050323486328e-05
ative 0.00016117095947265625
▁US 0.1126708984375
▁market 0.0772705078125
. 0.09429931640625
<0x0A> 0.27978515625
<0x0A> 0.11920166015625
The 1.681640625
▁company 0.68359375
▁will 3.453125
▁spend 1.5625
▁$ 1.4609375
2 1.6591796875
5 1.7421875
0 2.6171875
▁million 0.3310546875
▁on 0.8896484375
▁R 0.75244140625
& 0.0024566650390625
D 0.0019388198852539062
▁in 1.1650390625
▁ 0.78515625
2 0.0015726089477539062
0 0.00024139881134033203
2 0.480712890625
1 1.40234375
, 0.42919921875
▁up 0.94384765625
▁from 0.039764404296875
▁$ 0.260009765625
1 0.011199951171875
4 0.059295654296875
0 0.4501953125
▁million 0.0357666015625
▁last 1.4189453125
▁year 0.0311431884765625
. 0.78759765625
▁The 1.62890625
▁bulk 2.91015625
▁of 0.01812744140625
▁the 0.5498046875
▁fund 2.751953125
ing 0.00689697265625
▁will 0.26953125
▁support 3.49609375
▁late 4.40625
- 0.0980224609375
stage 0.004238128662109375
▁clin 0.60302734375
ical 0.00040340423583984375
▁tri 0.145263671875
als 6.771087646484375e-05
▁of 1.04296875
▁its 1.01953125
▁experimental 4.55078125
▁gene 0.56005859375
▁ther 0.0265960693359375
apy 0.125244140625
▁for 0.89892578125
▁sp 4.0625
inal 0.003147125244140625
▁mus 0.0016584396362304688
cular 0.0020885467529296875
▁at 0.001644134521484375
ro 0.0011930465698242188
phy 6.794929504394531e-06
▁( 0.52294921875
S 0.006435394287109375
MA 0.0004627704620361328
), 0.459228515625
▁a 0.72412109375
▁rare 0.8876953125
▁neur 2.619140625
om 0.0014467239379882812
us 0.0001398324966430664
cular 0.0008540153503417969
▁disease 0.35546875
▁that 0.53955078125
▁is 2.810546875
▁the 0.53564453125
▁leading 0.2088623046875
▁gen 0.2509765625
etic 0.00501251220703125
▁cause 0.0229034423828125
▁of 0.0027256011962890625
▁infant 0.66015625
▁death 0.5634765625
. 0.34423828125
▁If 4.24609375
▁approved 0.384765625
, 0.1434326171875
▁the 0.57861328125
▁treatment 1.0986328125
▁would 0.970703125
▁be 0.3857421875
▁the 0.1185302734375
▁first 0.07476806640625
▁gene 0.6708984375
▁ther 0.0197906494140625
apy 0.0003345012664794922
▁for 0.798828125
▁S 0.38427734375
MA 0.0001653432846069336
. 1.369140625
<0x0A> 0.269287109375
<0x0A> 0.022369384765625
“ 3.341796875
This 2.421875
▁boost 7.98828125
ed 3.228515625
▁invest 0.92333984375
ment 0.0005359649658203125
▁in 1.19921875
▁research 2.0390625
▁fund 7.8359375
ing 0.039398193359375
▁demonstr 3.119140625
ates 0.00022864341735839844
▁our 0.1934814453125
▁commit 0.74755859375
ment 8.26120376586914e-05
▁to 0.01264190673828125
▁bringing 1.732421875
▁potentially 3.51953125
▁life 0.77783203125
- 0.0234832763671875
ch 0.468994140625
anging 1.6927719116210938e-05
▁ther 1.259765625
ap 0.0032100677490234375
ies 2.4199485778808594e-05
▁to 0.0511474609375
▁patients 0.349853515625
▁as 2.423828125
▁quickly 0.195068359375
▁as 0.11090087890625
▁possible 0.0162811279296875
,” 0.246826171875
▁said 0.243408203125
▁Eth 1.623046875
ical 0.0020999908447265625
▁Hold 0.172119140625
ings 0.0120697021484375
▁CE 0.457763671875
O 0.00013875961303710938
▁Emma 7.33984375
▁Thompson 5.77734375
. 0.5126953125
▁“ 0.408203125
We 0.8330078125
▁have 2.44921875
▁prom 7.578125
ising 0.00017273426055908203
▁treat 4.73828125
ments 4.494190216064453e-05
▁in 0.6376953125
▁our 1.0126953125
▁pipeline 0.265625
▁for 1.8857421875
▁S 2.572265625
MA 0.004047393798828125
▁and 0.560546875
▁other 0.84912109375
▁rare 0.66455078125
▁dise 0.1712646484375
ases 1.7404556274414062e-05
, 0.374267578125
▁and 0.105224609375
▁now 5.47265625
▁is 0.62890625
▁the 0.02099609375
▁time 0.08758544921875
▁to 0.061859130859375
▁drive 4.9609375
▁them 0.9755859375
▁across 5.65234375
▁the 0.040130615234375
▁finish 0.25244140625
▁line 0.00045490264892578125
.” 0.274169921875
<0x0A> 0.0262451171875
<0x0A> 0.041717529296875
The 1.3251953125
▁sur 6.1953125
ge 0.01065826416015625
▁in 0.00981903076171875
▁R 0.53759765625
& 0.00012791156768798828
D 0.00028324127197265625
▁sp 0.17529296875
ending 1.6927719116210938e-05
▁comes 0.5390625
▁as 0.434326171875
▁Eth 0.548828125
ical 0.0002415180206298828
▁Hold 0.01406097412109375
ings 7.43865966796875e-05
▁ram 4.16796875
ps 2.384185791015625e-06
▁up 0.00080108642578125
▁efforts 1.5205078125
▁to 0.01430511474609375
▁break 4.55078125
▁into 0.01219940185546875
▁the 0.0200653076171875
▁US 0.5361328125
▁health 5.33203125
care 0.10791015625
▁market 0.06689453125
. 0.435546875
▁The 0.48095703125
▁US 4.75390625
▁accounts 1.7333984375
▁for 0.0002713203430175781
▁nearly 1.859375
▁half 0.990234375
▁of 0.03936767578125
▁global 1.125
▁bi 2.22265625
ote 0.346923828125
ch 0.09796142578125
▁reven 2.072265625
ues 5.888938903808594e-05
, 0.402099609375
▁but 2.720703125
▁Eth 4.16015625
ical 0.0004525184631347656
▁Hold 0.0289459228515625
ings 0.00323486328125
▁currently 2.21484375
▁has 0.8291015625
▁no 0.319091796875
▁presence 1.8193359375
▁in 0.450439453125
▁the 0.0457763671875
▁country 0.34130859375
. 0.11041259765625
▁Its 4.96875
▁S 2.671875
MA 0.00998687744140625
▁treatment 0.8017578125
▁is 0.83544921875
▁approved 3.00390625
▁in 0.19775390625
▁Europe 0.69482421875
, 1.203125
▁but 1.7021484375
▁US 4.49609375
▁regul 0.5341796875
atory 2.666015625
▁appro 0.509765625
val 5.078315734863281e-05
▁would 2.919921875
▁open 2.60546875
▁up 0.300537109375
▁a 0.435546875
▁much 1.625
▁larger 0.201416015625
▁commercial 4.30078125
▁opportunity 0.35888671875
. 0.342041015625
▁The 3.2734375
▁company 0.441162109375
▁plans 1.5654296875
▁to 0.00782012939453125
▁file 1.9912109375
▁for 0.6181640625
▁US 0.9482421875
▁appro 0.43115234375
val 9.894371032714844e-06
▁of 1.69140625
▁the 0.59228515625
▁S 1.4541015625
MA 0.00014853477478027344
▁ther 2.044921875
apy 0.00027561187744140625
▁by 1.69140625
▁mid 3.31640625
- 0.0222015380859375
2 0.1290283203125
0 5.888938903808594e-05
2 0.007534027099609375
1 1.3134765625
. 0.3369140625
<0x0A> 0.0653076171875
<0x0A> 0.035186767578125
To 4.16015625
▁support 0.50390625
▁its 0.166259765625
▁US 0.7138671875
▁expansion 0.289794921875
, 0.2255859375
▁Eth 0.08135986328125
ical 6.73532485961914e-05
▁Hold 0.001316070556640625
ings 3.2782554626464844e-05
▁also 4.37109375
▁announced 0.8603515625
▁the 2.154296875
▁opening 2.09375
▁of 0.0013179779052734375
▁its 2.62890625
▁US 1.8671875
▁headquarters 0.15771484375
▁in 0.051300048828125
▁Boston 1.142578125
, 1.0029296875
▁a 4.27734375
▁hub 2.33984375
▁for 0.19970703125
▁bi 0.81787109375
ote 0.0301055908203125
ch 0.1588134765625
▁innov 0.79931640625
ation 0.0009636878967285156
. 0.578125
▁The 0.2021484375
▁company 0.39208984375
▁has 1.8896484375
▁h 0.8193359375
ired 6.747245788574219e-05
▁several 2.2421875
▁execut 1.93359375
ives 1.52587890625e-05
▁with 0.81298828125
▁experience 0.677734375
▁bringing 4.70703125
▁gene 1.8681640625
▁ther 0.01474761962890625
ap 0.04302978515625
ies 8.821487426757812e-06
▁to 0.11358642578125
▁market 0.28564453125
▁to 5.80078125
▁staff 6.0
▁its 0.98583984375
▁US 0.5205078125
▁office 2.740234375
. 0.73291015625
▁▁ 6.21484375
<0x0A> 0.0227813720703125
<0x0A> 0.1553955078125
“ 1.6240234375
The 1.7265625
▁US 0.35986328125
▁launch 7.546875
▁is 1.2275390625
▁a 0.513671875
▁mil 3.720703125
estone 2.4080276489257812e-05
▁we 3.72265625
▁have 1.185546875
▁been 0.141357421875
▁moving 5.6796875
▁toward 0.54345703125
▁for 0.1673583984375
▁years 1.9150390625
▁now 4.734375
. 3.59375
▁With 2.654296875
▁a 2.416015625
▁proven 4.46875
▁treatment 2.5
, 2.939453125
▁a 0.8037109375
▁newly 8.1796875
▁bol 4.62890625
ster 8.344650268554688e-06
ed 6.318092346191406e-05
▁team 1.5966796875
, 0.560546875
▁and 0.0193634033203125
▁strong 3.572265625
▁financial 2.41015625
▁backing 0.30029296875
, 0.1475830078125
▁we 0.294921875
▁are 0.385498046875
▁ready 1.32421875
▁to 0.0479736328125
▁introduce 5.49609375
▁Eth 1.7978515625
ical 0.0006489753723144531
▁Hold 0.071533203125
ings 0.002788543701171875
▁to 0.424560546875
▁American 2.74609375
▁patients 0.1192626953125
▁and 0.8251953125
▁share 5.8125
hold 0.0220947265625
ers 0.00013518333435058594
,” 0.11358642578125
▁said 0.177001953125
▁M 6.1328125
s 0.78466796875
. 0.236572265625
▁Thompson 0.0143890380859375
. 0.0220794677734375
<0x0A> 0.32568359375
<0x0A> 0.124267578125
E 1.2744140625
th 0.020538330078125
ical 0.00021159648895263672
▁Hold 0.002666473388671875
ings 0.0018520355224609375
’ 1.8251953125
▁stock 2.8046875
▁price 1.1025390625
▁rose 1.7470703125
▁ 0.96044921875
4 2.462890625
% 0.2486572265625
▁on 0.693359375
▁the 0.22314453125
▁news 0.16162109375
▁of 1.0771484375
▁its 2.046875
▁increased 1.4306640625
▁R 0.40478515625
& 0.00011372566223144531
D 0.0006413459777832031
▁sp 0.1793212890625
ending 1.6808509826660156e-05
▁and 0.62060546875
▁planned 3.77734375
▁US 0.1826171875
▁launch 1.447265625
. 0.09375
▁In 3.103515625
vest 0.0682373046875
ors 0.0298919677734375
▁see 4.7109375
▁an 6.07421875
▁opportunity 1.380859375
▁for 0.88330078125
▁the 1.0146484375
▁company 0.08123779296875
▁to 0.06878662109375
▁significantly 6.43359375
▁expand 0.9814453125
▁re 4.296875
venue 8.225440979003906e-05
▁if 2.783203125
▁it 1.58203125
▁can 0.4130859375
▁gain 1.5419921875
▁US 1.5546875
▁appro 0.58349609375
val 4.887580871582031e-06
▁for 0.168701171875
▁its 0.028961181640625
▁S 0.335205078125
MA 5.53131103515625e-05
▁treatment 0.333251953125
▁and 1.2041015625
▁other 2.369140625
▁experimental 2.251953125
▁ther 0.4541015625
ap 4.470348358154297e-05
ies 3.421306610107422e-05
▁in 0.85888671875
▁the 2.126953125
▁coming 3.515625
▁years 0.0178375244140625
. 0.00959014892578125
▁With 4.921875
▁a 1.03515625
▁full 9.046875
▁pipeline 1.794921875
▁of 0.081787109375
▁gene 2.693359375
▁ther 0.0187530517578125
ap 0.1097412109375
ies 1.8358230590820312e-05
▁and 2.38671875
▁now 8.53125
▁the 2.31640625
▁means 3.859375
▁to 0.01371002197265625
▁bring 0.78076171875
▁them 0.141357421875
▁to 0.027069091796875
▁market 0.08709716796875
, 0.2783203125
▁Eth 0.405517578125
ical 0.00014257431030273438
▁Hold 0.0018749237060546875
ings 0.0011043548583984375
▁is 0.462158203125
▁po 1.0087890625
ised 0.0001304149627685547
▁to 0.293212890625
▁become 0.6943359375
▁an 4.87109375
▁emer 4.8671875
ging 0.0035648345947265625
▁player 0.91455078125
▁in 0.00365447998046875
▁the 0.02972412109375
▁global 2.5546875
▁bi 0.12548828125
ote 0.03936767578125
ch 0.035888671875
▁industry 0.368896484375
. 0.02813720703125
